Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001558370-22-006260
Filing Date
2022-04-28
Accepted
2022-04-28 16:01:14
Documents
62
Period of Report
2022-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q glyc-20220331x10q.htm   iXBRL 10-Q 1041124
2 EX-5.1 glyc-20220331xex5d1.htm EX-5.1 10990
3 EX-10.1 glyc-20220331xex10d1.htm EX-10.1 214459
4 EX-31.1 glyc-20220331xex31d1.htm EX-31.1 16953
5 EX-31.2 glyc-20220331xex31d2.htm EX-31.2 16769
6 EX-32.1 glyc-20220331xex32d1.htm EX-32.1 9432
7 GRAPHIC glyc-20220331xex5d1001.jpg GRAPHIC 5842
  Complete submission text file 0001558370-22-006260.txt   5120488

Data Files

Seq Description Document Type Size
8 EX-101.SCH glyc-20220331.xsd EX-101.SCH 34562
9 EX-101.CAL glyc-20220331_cal.xml EX-101.CAL 36324
10 EX-101.DEF glyc-20220331_def.xml EX-101.DEF 162574
11 EX-101.LAB glyc-20220331_lab.xml EX-101.LAB 295173
12 EX-101.PRE glyc-20220331_pre.xml EX-101.PRE 280796
56 EXTRACTED XBRL INSTANCE DOCUMENT glyc-20220331x10q_htm.xml XML 782749
Mailing Address 9708 MEDICAL CENTER DRIVE ROCKVILLE MD 20850
Business Address 9708 MEDICAL CENTER DRIVE ROCKVILLE MD 20850 240-243-1201
GLYCOMIMETICS INC (Filer) CIK: 0001253689 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-36177 | Film No.: 22866332
SIC: 2834 Pharmaceutical Preparations